The genus *Rickettsia* contains ≈25 validated species of bacteria; another 25 isolates that have not been fully characterized or have not received a species designation have also been described. Signs and symptoms of human rickettsiosis caused by spotted fever group *Rickettsia* spp. include an inoculation eschar (a necrotic area at the site of the tick bite that might not be always present), fever, local adenopathies, and rash, although some variability can be found, depending on the infecting *Rickettsia* species.

*R. sibirica mongolitimonae* (also spelled *mongolotimonae*) was isolated from a *Hyalomma asiaticum* tick collected in the Alashian region of Inner Mongolia in 1991 ([@R1]). Designated *R. mongolitimonae*, the organism was identified as a member of the *R. sibirica* species complex ([@R2]), but further phylogenetic analyses grouped it in a cluster separate from other strains of *R. sibirica*.

The first human case of infection with *R. sibirica mongolitimonae* was reported in France in 1996 ([@R3]); since then, 18 additional cases have been described in the literature ([@R4]--[@R14]). Clinical signs and symptoms of infection are fever; a discrete, maculopapular rash; and enlarged regional lymph nodes, with or without lymphangitis. Although *R. sibirica mongolitimonae* infection causes a mild, not fatal, disease, complications such as acute renal failure and retinal vasculitis have been noted ([@R7],[@R10]). We report 6 cases of human *R. sibirica mongolitimonae* infection from the same geographic region of Spain.

The Study
=========

During July 2007--July 2011, six patients from the Mediterranean coast city of Elche, Spain, who had high fever and inoculation eschars received a diagnosis of infection with *R. sibirica mongolitimonae* ([Table](#T1){ref-type="table"}). For laboratory confirmation, DNA was extracted from eschars, lymph nodes (fine-needle aspiration), and blood samples by using the QIAamp Tissue Kit (QIAGEN, Hilden, Germany), according to the manufacturer's instructions. For molecular detection, 200--400 ng of DNA from each sample was subjected to PCR targeting the 23S-5S rRNA intergenic spacer, followed by hybridization with specific probes by reverse line blotting, as described ([@R15]). When using the probe for *R. sibirica mongolitimonae*, a positive hybridization signal was obtained from eschar samples from all 6 patients; this result was confirmed by sequencing (100% similarity to a reference *R. sibirica mongolitimonae* strain \[GenBank accession no. HQ710799\] in all cases in the 357 bp sequenced). To further confirm this result, nested PCR targeting the gene for outer membrane protein A was performed as described ([@R15]); these sequences (514 bp) also showed 100% similarity to a reference *R. sibirica mongolitimonae* strain (GenBank accession no. HQ728350).

###### Epidemiologic, clinical, and microbiologic characteristics associated with 6 case-patients infected with *Rickettsia sibirica mongolitimonae*, Spain, 2007--2011\*

  Characteristic                                  Patient 1                Patient 2                 Patient 3               Patient 4               Patient 5            Patient 6
  ----------------------------------------------- ------------------------ ------------------------- ----------------------- ----------------------- -------------------- -----------------------
  Patient age, y/sex                              67/F                     32/M                      33/M                    42/F                    40/F                 75/F
  Date of illness onset                           2007 Jul                 2009 Sep                  2010 Apr                2011 Mar                2011 Apr             2011 Jul
  Type of residence                               Rural                    Urban                     Urban                   Rural                   Rural                Rural
  At-risk activity                                Gardening                Working at golf courses   Walking in rural area   Walking in rural area   Excursion by horse   Walking in rural area
  Report of tick bite                             No                       No                        No                      No                      Yes                  No
  Duration of fever, d                            10                       4                         5                       5                       6                    4
  Temperature, °C                                 38.5                     39.5                      39.4                    39.0                    39.0                 39.2
  Headache                                        Yes                      Yes                       Yes                     Yes                     Yes                  Yes
  Myalgia                                         Yes                      Yes                       Yes                     Yes                     Yes                  Yes
  Location of eschar                              Scalp                    Thigh                     Leg                     Shoulder                Neck                 Leg
  Location of enlarged regional lymph nodes       Retroauricular           Inguinal                  Inguinal                Supraclavicular         Retroauricular       None
  Lymphangitis                                    No                       Yes                       Yes                     No                      No                   Yes
  Rash                                            Yes                      Yes                       No                      No                      Yes                  Yes
  Leukocytes, × 10^3^ cells/μL                    11.1                     2.93                      6.40                    6.05                    NA                   NA
  Platelets, × 10^3^/μL                           540                      126                       198                     217                     NA                   NA
  AST, IU                                         79                       50                        48                      NA                      NA                   NA
  ALT, IU                                         65                       53                        27                      NA                      NA                   NA
  C-reactive protein, mg/dL                       101                      44                        46                      15.4                    NA                   NA
  Lactate dehydrogenase, IU                       642                      567                       NA                      NA                      NA                   NA
  Treatment                                       Doxycycline              Azithromycin              Doxycycline             Doxycycline             Doxycycline          Doxycycline
  Complications                                   Hyponatremia, lethargy   NA                        NA                      NA                      NA                   NA
  PCR results                                                                                                                                                             
  Eschar                                          Positive                 Positive                  Positive                Positive                Positive             Positive
  Lymph nodes                                     NA                       Negative                  Negative                NA                      NA                   NA
  Whole blood                                     Negative                 NA                        NA                      NA                      NA                   NA
  IgM/IgG against *R. sibirica mongolitimonae*†                                                                                                                           
  Acute-phase sample                              40/160                   \<20/\<40                 \<20/\<40               NA                      40/160               \<20/80
  Convalescent-phase sample                       NA                       NA                        \<20/\<40               \<20/40                 \<20/80              \<20/80
  IgM/IgG against *R. conorii*†                                                                                                                                           
  Acute-phase sample                              40/160                   \<20/\<40                 \<20/\<40               NA                      40/160               \<20/40
  Convalescent-phase sample                       NA                       NA                        \<20/\<40               \<20/40                 \<20/80              \<20/40

\*NA, not available; AST, aspartate aminotransferase; ALT, alanine aminotransferase. †Determined by using in-house microimmnunofluorescence assay.

Serologic response was analyzed by using an in-house microimmunofluorescence assay for IgG and IgM, performed as described ([@R4]); *R. conorii* and *R. sibirica mongolitimonae* were used as antigens, and cutoff values were 1:40 for IgG and 1:20 for IgM. Acute- and convalescent-phase serum samples were obtained from 3 case-patients and single serum samples from the other 3 case-patients. Results for samples from 2 case-patients were negative, but results for the remaining 4 samples showed low to medium titers. Two samples were positive for IgM and 4 positive for IgG ([Table](#T1){ref-type="table"}). These results are consistent with previous reports ([@R6]), in which ≈30% of cases had a positive IgM result and ≈50% had negative or near-cutoff IgG results.

All 6 case-patients lived in Elche and its surroundings (230,112 inhabitants). Three of the cases occurred during the spring, which is when 10/18 cases reported in the literature occurred ([@R4]--[@R14]). All 6 case-patients had fever (38.5°C--39.5°C), myalgia, and headache; in the cases from the literature, 18/18 patients had fever, 13/18 myalgia, and 11/18 headache. In our study, 1 case-patient was confused and drowsy on arrival at the emergency department.

All 6 case-patients had a single inoculation eschar develop: 2 on the neck, 2 on a lower limb ([Figure](#F1){ref-type="fig"}), 1 on the scalp, and 1 on an upper limb. Five (83%) case-patients had enlarged lymph nodes in the region from which the eschar drained, as reported for 10/18 (55%) cases from the literature. Three case-patients (50%) had lymphangitis extending from the eschar to the draining lymph nodes ([Figure](#F1){ref-type="fig"}), compared with 6/18 (33%) in cases from the literature.

![Inoculation eschar on popliteal area and discrete maculopapular elements in patient with lymphangitis infected with *Rickettsia sibirica mongolitimonae*, Spain, 2011.](11-1706-F){#F1}

For 4/6 (67%) case-patients, a generalized maculopapular rash developed on the palms and soles but not the face; for 2 case-patients, a discrete maculopapular rash appeared after 1 day of treatment. These findings are consistent with our review of the literature, which indicated rash occurring in 13/18 (72%) cases. All 6 case-patients recovered without sequelae after antimicrobial drug treatment using doxycycline or azithromycin.

Conclusions
===========

Fournier et al. ([@R4]), who reported 7 cases of *R. sibirica mongolitimonae* infection in 2005, proposed the name lymphangitis-associated rickettsiosis for the disease, on the basis of associated clinical features. However, for the case-patients reported here, the most common clinical signs and symptoms were fever and skin eschar, similar to those from previously reported case series; 5 of the case-patients reported here showed regional lymph node enlargement, 4 rash, and 3 lymphangitis. Because only 24 total cases have been reported and other rickettsioses produce lymphadenopathy and lymphangitis, the term lympangitis-associated rickettsiosis may be unwarranted for this disease.

In our case series, 1 case-patient had mental confusion after 10 days of a febrile disease before hospitalization and was found to be hyponatremic. In this patient, the eschar was located on the scalp, and neither rash nor other clinical clues were suggestive of rickettsiosis. The patient had increased C-reactive protein plasma levels and the highest serologic antibody titers for *R. sibirica mongolitimonae* of the 6 case-patients ([Table](#T1){ref-type="table"}, patient 1).

Since *R. sibirica mongolitimonae* was isolated from *H. asiaticum* ticks in 1991 ([@R1]), it has been recovered from *H. truncatum* ticks in sub-Saharan Africa ([@R6]) and *H. anatolicum excavatum* ticks in Greece ([@R7]). These findings suggest a possible association between *R. sibirica mongolitimonae* and *Hyalomma* spp. ticks. However, in Spain, *R. sibirica mongolitimonae* has been detected in 2/8 tick species tested (*Rhipicephalus pusillus* and *Rh. bursa*) at similar percentages (3.7% and 3.6%, respectively) but not from *Hyalomma* spp. ticks ([@R15]). Similarly, 1/20 samples of *Rh. pusillus* ticks from Portugal was positive for *R. sibirica mongolitimonae* ([@R8]), while testing of other tick species, including *H. lusitanicum, Rh. sanguineus*, and *Rh. bursa,* yielded negative results. That *Hyalomma* spp. (*H. lusitanicum* and *H. marginatum*) ticks have not been found to be infected in Spain does not mean that these ticks are not vectors for *R. sibirica mongolitimonae*. However, data from the literature support the hypothesis that *Rhipicephalus* spp. ticks are a vector for this rickettsia on the Iberian Peninsula, and our findings confirm that this rickettsia species is circulating in Spain, where specific vectors have yet to be described.

In summary, we report 6 cases of human infection with *R. sibirica mongolitimonae* that occurred in the same geographic area of Spain. Our results indicate that PCR of eschar samples is the most useful diagnostic procedure for this pathogen; samples from all 6 case-patients had positive results, while test results for 1 whole blood sample and 2 lymph node samples were negative. However, the limited number of samples does not make it possible to infer specific diagnostic sensitivities.

The epidemiology and pathogenicity of illness caused by *R. sibirica mongolitimonae* infection require further investigation. An active search for the vector of *R. sibirica mongolitimonae* in countries of the Mediterranean region is necessary to complete the epidemiology of this rickettsiosis, which is likely to be more widespread than originally assumed. In particular, clinicians caring for patients who have traveled to the Mediterranean coast of Spain should consider this rickettsiosis in the differential diagnosis.
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